Business Standard
Thursday, Feb 16, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Glaxo Q4 net profit soars 157%
BS Reporter / Mumbai Feb 19, 2009, 00:40 IST

Exceptional income of over Rs 130 crore helped Glaxo Pharmaceuticals post a 157 per cent higher net profit at Rs 208.4 crore for the fourth quarter ended December 2008, compared to Rs 80.9 crore for the corresponding previous quarter in 2007. Total income for the fourth quarter was at

Rs 375.5 crore, 5.15 per cent higher than the Rs 357.1 crore for the fourth quarter in 2007. Consolidated net profit was up by 7.94 per cent at Rs 591 crore for the year ended December, 2008, where as the same was at

 Click here for Cloud Computing
 
Rs 547.5 crore in the previous year.

GSK India posted a total income of Rs 1742.6 crore for the year ended December 31, 2008, 5.31 per cent higher than the Rs 1654.6 crore income for the year ended December 31, 2007.

GSK India accounted for the quarter an exceptional income earned during the year from the profit on sale of investments (the company had divested its fine chemical business last year) of Rs 131 crore and another Rs 15.5 crore related to long term liabalities such as retirement benefits, explained a company executive.

The growth in net sales excluding the fine chem business, was 10.1 per cent and net profit grew by 14.6 per cent for the year ended December 31, 2008 on a comparable basis, he said.

“The year has seen creation of new capabilities for the business through the entry into oncology and the cardiovascular therapeutic areas, besides new vaccine launches,” said Hasit B Joshipura, managing director.

The continued focus on sales of priority products, new product introductions and tight expense control helped improve profits.

This was achieved despite cost escalations of certain imported ingredients and inflationary pressures on utilities and freight costs. Higher income from investments contributed further to the improvement in profits, he explained.

GSK has recommended a special additional dividend of Rs 18 per equity share, considering the cash position of the company. If approved by the shareholders, the special additional dividend will absorb Rs 152 crore. The company had declared a dividend of Rs 22 per equity share for the year.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- S&P reaches 7-month high before hitting wall
- World Bank President Zoellick to step down on June 30
- Oil cos cut jet fuel prices by Rs 350/kl
- Telcos operating profit to rise 5% in 2 yrs: Crisil
- PESB recommends SS Narsing Rao for CIL's top slot
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Save over Rs.3000 with IndianOil Citibank Card
- We live for our family. have you secured them?
- India's No. 1 Property Site. Click here to know more..
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Get 5% cashback on telephone bills with Citi
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Medium-sized businesses are the engines of a smarter planet.
- Be part of it The World's Largest Aircraft.
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Office 365 for professionals and small businesses.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
- Health is Wealth..... Insurance + Savings... Know More...
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Kanika Datta: The importance of being SRK
- Leela parts ways with Kempinski
- Tata Motors soars to record level as JLR propels profit
- Tailor-made but not good enough
- Nestle: Food for thought
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only
  Buy Now
  Now available on the Kindle Store...
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us